The acquisition strengthens PPD’s ability to provide a broad range of clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs services to its growing client base in the Balkans and surrounding countries, said PPD.
AbCRO marks PPD’s second acquisition in central and eastern Europe. PPD acquired InnoPharm, an independent contract research organization based in Smolensk, Russia in 2008.
Fred Eshelman, CEO of PPD, said: “Eastern Europe is a strong, emerging area for clinical research. AbCRO’s reputation as a premier contract research organization in this region builds upon our ability to conduct global trials in an area we continue to target for expansion.”